The present invention provides novel compounds represented by the general formula(I): their stereoisomers, pharmaceutically acceptable salts and their pharmaceuticallyacceptable solvates thereof, which are useful in treating metabolic disordersrelated to insulin resistance or hyperglycemia. The invention also relatesto a process for the manufacture of compounds of formula (I) and pharmaceuticalcompositions containing them.